Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationCombined Modality TherapyTransplantation ConditioningAntineoplastic Combined Chemotherapy ProtocolsTransplantation, HomologousMelphalanCyclophosphamideGranulocyte Colony-Stimulating FactorLeukapheresisHematologic NeoplasmsAntigens, CD34Blood Component RemovalTreatment OutcomeStem Cell TransplantationMultiple MyelomaLymphoma, Non-HodgkinMyeloablative AgonistsBusulfanGraft vs Host DiseaseGraft SurvivalBone Marrow TransplantationEtoposideThiotepaHematopoietic Stem CellsAntineoplastic Agents, AlkylatingRemission InductionSalvage TherapyRecurrenceCarmustineCytophagocytosisIfosfamideAntineoplastic AgentsVincristineAmyloidosisDisease-Free SurvivalCytarabineHodgkin DiseaseStem CellsHematopoiesisCord Blood Stem Cell TransplantationNeoplasmsSurvival RateTransplantation ChimeraRetrospective StudiesTissue DonorsDoxorubicinSurvival AnalysisTime FactorsWhole-Body IrradiationInfectionLymphoma, T-CellCarboplatinPlatelet CountPOEMS SyndromeHistocompatibilityImmunosuppressive AgentsPrednisoneHistocompatibility TestingFollow-Up StudiesLeukemia, Myeloid, AcuteDexamethasoneTransplantation, IsogeneicVidarabineBlood Cell CountRecombinant ProteinsProspective StudiesLeukemiaLymphomaBone Marrow PurgingFatal OutcomeCytomegalovirus InfectionsBlood CellsFeasibility StudiesGraft vs Leukemia EffectMyelodysplastic SyndromesChemotherapy, AdjuvantPrognosisImmunophenotypingAnemia, AplasticBreast NeoplasmsLiver TransplantationBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporineT-LymphocytesLeukocytes, MononuclearBone MarrowOpportunistic InfectionsHistiocytosis, Non-Langerhans-CellLivedo ReticularisHLA AntigensImmunosuppressionBlood DonorsPilot Projects